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Abstract. 
 
We report the identification and character-
ization of ERS-24 (Endoplasmic Reticulum SNARE of 
24 kD), a new mammalian v-SNARE implicated in ve-
sicular transport between the ER and the Golgi. ERS-
24 is incorporated into 20S docking and fusion particles 
and disassembles from this complex in an ATP-depen-
dent manner. ERS-24 has significant sequence homol-
ogy to Sec22p, a v-SNARE in 
 
Saccharomyces cerevisiae
 
 
required for transport between the ER and the Golgi. 
ERS-24 is localized to the ER and to the Golgi, and it is 
enriched in transport vesicles associated with these or-
ganelles.
 
N
 
ewly 
 
 formed transport vesicles have to be selec-
tively targeted to their correct destinations, im-
plying the existence of a set of compartment-spe-
cific proteins acting as unique receptor–ligand pairs. Such
proteins have now been identified (Söllner et al., 1993
 
a
 
;
Rothman, 1994): one partner efficiently packaged into
vesicles, termed a v-SNARE,
 
1
 
 and the other mainly local-
ized to the target compartment, a t-SNARE. Cognate
pairs of v- and t-SNAREs, capable of binding each other
specifically, have been identified for the ER–Golgi trans-
port step (Lian and Ferro-Novick, 1993; Søgaard et al.,
1994), the Golgi–plasma membrane transport step (Aalto
et al., 1993; Protopopov et al., 1993; Brennwald et al.,
1994) in 
 
Saccharomyces cerevisiae
 
, and regulated exocyto-
sis in neuronal synapses (Söllner et al., 1993
 
a
 
; for reviews
see Scheller, 1995; Südhof, 1995). Additional components,
like p115, rab proteins, and sec1 proteins, appear to regu-
late vesicle docking by controlling the assembly of
SNARE complexes (Søgaard et al., 1994; Lian et al., 1994;
Sapperstein et al., 1996; Hata et al., 1993; Pevsner et al.,
1994).
In contrast with vesicle docking, which requires com-
partment-specific components, the fusion of the two lipid
bilayers uses a more general machinery derived, at least in
part, from the cytosol (Rothman, 1994), which includes an
ATPase, the 
 
N
 
-ethylmaleimide–sensitive fusion protein
(NSF) (Block et al., 1988; Malhotra et al., 1988), and solu-
ble NSF attachment proteins (SNAPs) (Clary et al., 1990;
Clary and Rothman, 1990; Whiteheart et al., 1993). Only
the assembled v–t-SNARE complex provides high affinity
sites for the consecutive binding of three SNAPs (Söllner
et al., 1993
 
b
 
; Hayashi et al., 1995) and NSF. When NSF is
inactivated in vivo, v–t-SNARE complexes accumulate,
confirming that NSF is needed for fusion after stable dock-
ing (Søgaard et al., 1994).
The complex of SNAREs, SNAPs, and NSF can be iso-
lated from detergent extracts of cellular membranes in the
presence of ATP
 
g
 
S, or in the presence of ATP but in the
absence of Mg
 
2
 
1
 
, and sediments at 
 
z
 
20 Svedberg (20S
particle) (Wilson et al., 1992). In the presence of MgATP,
the ATPase of NSF disassembles the v–t-SNARE complex
and also releases SNAPs. It seems likely that this step
somehow initiates fusion.
To better understand vesicle flow patterns within cells, it
is clearly of interest to identify new SNARE proteins.
Presently, the most complete inventory is in yeast, but im-
munolocalization is difficult in yeast compared with ani-
mal cells, and many steps in protein transport have been
reconstituted in animal extracts (Rothman, 1992) that
have not yet been developed in yeast. Therefore, it is im-
portant to create an inventory of SNARE proteins in ani-
mal cells. The most unambiguous and direct method for
isolating new SNAREs is to exploit their ability to assem-
ble together with SNAPs and NSF into 20S particles and
to disassemble into subunits when NSF hydrolyzes ATP.
Similar approaches have already been successfully used to
isolate new SNAREs implicated in ER to Golgi (Søgaard
et al., 1994) and intra-Golgi transport (Nagahama et al.,
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N
 
-ethylmaleimide–sensitive factor; SNAP, soluble NSF attachment pro-
tein; SNARE, SNAP receptor.
  
The Journal of Cell Biology, Volume 137, 1997 1018
 
1996), in addition to the original discovery of SNAREs in
the context of neurotransmission (Söllner et al., 1993
 
a
 
).
Using this method, we now report the isolation and de-
tailed characterization of ERS-24 (Endoplasmic Reticu-
lum SNARE of 24 kD), a new mammalian v-SNARE that
is localized to the ER and Golgi. ERS-24 is found in trans-
port vesicles associated with the transitional areas of the
ER and with the rims of Golgi cisternae, suggesting a role
for ERS-24 in vesicular transport between these two com-
partments.
 
Materials and Methods
 
Preparation of Membranes, Recombinant NSF, and 
GST–
 
a
 
-SNAP
 
Triton X-100–solubilized total membrane extracts were prepared from
CHO and RBL–2H3 cells as previously described (Söllner et al., 1993
 
a
 
).
Salt-washed dog pancreas microsomes were prepared as described
(Walter and Blobel, 1983) and were a kind gift of Dr. Martin Wiedmann
(Memorial Sloan-Kettering Cancer Center, New York). Recombinant
(His)
 
6
 
-NSF-myc and (His)
 
6
 
-
 
a
 
-SNAP were prepared as previously de-
scribed (Söllner et al., 1993
 
a
 
). Recombinant glutathione-
 
S
 
-transferase
(GST)–
 
a
 
-SNAP was constructed by inserting 
 
a
 
-SNAP cDNA (White-
heart et al., 1993) into a pGEX-2T vector (Pharmacia Fine Chemicals, Pis-
cataway, NJ). The GST–
 
a
 
-SNAP fusion protein was expressed in 
 
Escheri-
chia coli
 
 (XL1-BLUE) (Stratagene, La Jolla, CA) and purified from the
bacterial extract on glutathione agarose beads (Sigma Chemical Co., St.
Louis, MO).
 
Isolation of SNAREs from 20S Particles and
Peptide Sequencing
 
Procedures used to purify SNAREs were essentially as described (Söllner
et al., 1993
 
a
 
), except that Triton X-100–solubilized total membrane ex-
tracts were prepared from RBL-2H3 cells and the reaction was scaled
up by 
 
z
 
10-fold. The detergent-solubilized total membrane extract was in-
cubated with recombinant (His)
 
6
 
-
 
a
 
-SNAP and (His)
 
6
 
-NSF-myc in the re-
action buffer as previously described (Söllner et al., 1993
 
a
 
), except that
recombinant (His)
 
6
 
-
 
g
 
-SNAP was omitted. Subsequent binding of 20S
complexes to mouse anti-myc mAb (9E10) (Evan et al., 1985) and specific
elution of putative SNAREs from 20S particle in the presence of MgATP
were performed as previously described (Söllner et al., 1993
 
a
 
).
One of the released proteins migrated with an apparent molecular mass
of 22 kD in 18% SDS-High-Tris-Urea-PAGE (Schlenstedt et al., 1990),
and this protein was excised from a nitrocellulose filter after electroblot-
ting and staining with Ponceau S (Sigma Chemical Co.) This protein band
was further processed for internal amino acid sequence analysis essen-
tially as described (Tempst et al., 1990; Erdjument-Bromage et al., 1994).
Briefly, nitrocellulose-bound protein was in situ digested with trypsin, and
the resulting peptides were separated by microbore reverse phase–HPLC
(Lui et al., 1996; Elicone et al., 1994). Selected peptides were then sub-
jected to chemical microsequencing as described (Tempst et al., 1994).
 
Isolation of cDNA Clones Encoding ERS-24
 
Peptide sequences from two tryptic fragments, T3 and T7, were used to
generate degenerate PCR primers. These peptide sequences are under-
lined in Fig. 1. Degenerate oligonucleotide representing the sense primer
(5
 
9
 
) ATGCA(A,G)GA(A,G)GA(C,T)GA(A,G)CA (3
 
9
 
) encoded the
peptide sequence MQEDEQ in tryptic fragment T3. The antisense primer
(3
 
9
 
) AA(A,G)TA(A,G,T)CT(C,T)AA(A,G)CT(C,T)TG (5
 
9
 
) was de-
signed on the basis of the peptide sequence FIEFET in tryptic fragment
T7. 0.5 
 
m
 
M each of sense and antisense PCR primers was used for PCR
amplification. 5 
 
m
 
g of total cellular RNA prepared from RBL-2H3 cells
was reverse transcribed as described (Sambrook et al., 1989), and the
product was used as a template for PCR amplification. A major 300-bp
amplification product was subcloned into pBluescript KS
 
1
 
 vector (Strat-
agene), subsequently randomly labeled, and used as a probe to screen a
CHO cDNA phage library constructed with the Uni-ZAP XR vector (Strat-
agene).
Hybridization was done in duplicate filters at 60
 
8
 
C for 16–20 h in 5 
 
3
 
SSPE (1 
 
3
 
 
 
5
 
 0.18 M NaCl, 1 mM EDTA, 10 mM NaH
 
2
 
PO
 
4
 
, pH 7.4), 5 
 
3
 
Denhardt’s solution, and 0.5% SDS, in the presence of 20 mg/ml sonicated
herring sperm DNA. The filters were washed twice in 2 
 
3
 
 SSC (1 
 
3
 
 
 
5
 
0.15 M NaCl, 15 mM sodium citrate, pH 7.0) for 30 min at room tempera-
ture, followed by two washes at 60
 
8
 
C in 2 
 
3
 
 SSC containing 0.1% SDS for
30 min, and finally washed twice at 60
 
8
 
C in 1 
 
3
 
 SSC containing 0.1% SDS
for 15 min each. About 50 positive clones were identified when 500,000
plaques were screened. Positive clones were excised from the Uni-ZAP
XR vector as inserts in pBluescript SK
 
2
 
 by coinfection with the helper
phage, ExAssist, as described by the manufacturer (Stratagene), and then
sequenced for both sense and antisense strands via the dideoxynucleotide
method (Sanger et al., 1977).
 
Preparation of Antibodies and Western Blot Analysis
 
A fusion protein of ERS-24, ERS-24–myc(His)
 
6
 
, with a carboxy-terminal
extension containing a myc epitope (EQKLISEEDL) (Evan et al., 1985)
and six histidine residues, was constructed by inserting PCR-amplified
ERS-24 cDNA into a modified pET3a vector (Novagen, Madison, WI;
Søgaard et al., 1994). After overexpression in 
 
E. coli
 
 BL 21 (Novagen), re-
combinant ERS-24–myc(His)
 
6
 
 protein was purified by affinity chromatog-
raphy using Ni-NTA-agarose as described by the manufacturer (Qiagen,
Chatsworth, CA). ERS-24–myc(His)
 
6
 
 was further purified using a Mono-
Q column (Pharmacia Fine Chemicals) in a loading buffer containing 10 mM
Bis-Tris-Propane, pH 7.0, and retrieved from the flow-through. The puri-
fied recombinant ERS-24–myc(His)
 
6
 
 protein was injected into rabbits
for immunization. Positive antisera were purified by affinity chromatogra-
phy with recombinant ERS-24–myc(His)
 
6
 
 conjugated to CNBr-activated
Sepharose 4B (Pharmacia Fine Chemicals) (Harlow and Lane, 1988). The
eluated antibodies were dialyzed against 10 mM MOPS buffer, pH 7.4,
containing 50 mM KCl and 5% glycerol. The polyclonal anti–syntaxin 5
antibody was raised against the cytoplasmic domain of the hamster syn-
taxin 5 (residues 1–284) and affinity purified using the covalently coupled
antigen as described above.
For Western blot analysis, detergent-solubilized total membrane ex-
tracts were fractionated on 18% High-Tris-Urea-SDS-PAGE (Schlen-
stedt et al., 1990; Laemmli, 1970) and blotted onto nitrocellulose filters.
Filters were blocked with 5% milk powder in TBS and incubated with pri-
mary antibodies as indicated (affinity-purified polyclonal anti–ERS-24 an-
tibody diluted 1:100; affinity-purified polyclonal anti–GOS-28 antibody
[Nagahama et al., 1996] diluted 1:500; mAb (M3A5) recognizing 
 
b
 
-COP
[Duden et al., 1991] diluted 1:1,000; polyclonal anti–SSR
 
a
 
 antibody [Wada
et al., 1991] diluted 1:500; affinity-purified polyclonal anti–syntaxin 5 anti-
body diluted 1:100; polyclonal anti-p58 antibody [Saraste et al., 1987;
Lahtinen et al., 1992] diluted 1:1,000; monoclonal anti-BiP (grp 78) anti-
body (StressGen Biotechnologies Corp., Victoria, British Columbia, Can-
ada) diluted 1:200; and a polyclonal antibody against an amino-terminal
peptide of BiP diluted 1:1,000). Immunoreactive bands were visualized
with HRP-conjugated secondary antibodies (BioRad Laboratories, Her-
cules, CA) and enhanced chemiluminescence (ECL kit; Amersham Corp.,
Arlington Heights, IL).
 
Expression and Immunolocalization of the ERS-24–myc 
Fusion Protein in CHO Cells
 
A stable CHO cell line overexpressing epitope-tagged ERS-24 proteins
(ERS-24–myc) was generated for immunolocalization studies. A myc epi-
tope (EQKLISEEDL; Evan et al., 1985) encoding oligonucleotide was
added by PCR to the 3
 
9
 
 end of the coding region with a flexible linker en-
coding three repetitive units of a Ser-Gly-Gly peptide (Weissman and
Kim, 1992). The resulting constructs were subcloned into the mammalian
cell expression vector, pcDNA-3 (Invitrogen, San Diego, CA). CHO cells
were grown in MEM-
 
a
 
 medium containing 10% FCS and were trans-
fected with the epitope-tagged ERS-24 (ERS-24–myc in pcDNA-3) using
the Lipofectamine reagent as described by the manufacturer (GIBCO
BRL, Gaithersburg, MD). Cells were incubated in selection medium con-
taining 1.0 mg/ml G418 sulfate (GIBCO BRL) 48 h after transfection, and
subsequently subcloned using cloning cylinders 10–14 d after the initial
transfection. These stably transfected cell lines were maintained in the
presence of 0.5 mg/ml of G418 sulfate and examined for the expression of
ERS-24–myc by Western blot analysis using both the affinity-purified
polyclonal anti–ERS-24 antibody (1:100) and mAb 9E10 (1:500) (Evan et
al., 1985). 
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Immunolocalization of ERS-24 was performed using a stable CHO cell
line overexpressing the fusion ERS-24–myc protein. Indirect immunofluo-
rescence localization was performed as described (Louvard et al., 1982;
Warren et al., 1984). Cells were fixed with 3% paraformaldehyde (Poly-
sciences, Inc., Warrington, PA) and stained with antibodies as indicated:
affinity-purified polyclonal anti–ERS-24 antibody diluted 1:20, mAb anti-
BiP (grp-78) (StressGen) diluted 1:100, and mAb 9E10 diluted 1:100. The
secondary antibodies, FITC-conjugated goat anti–rabbit IgG (Vector
Labs) and Texas red–conjugated goat anti–mouse IgG (Molecular Probes,
Eugene, OR), were diluted 1:100. The stained cells were observed with an
Axiophot microscope using a 
 
3
 
100 objective oil immersion lens and a
 
3
 
10 eye piece (Carl Zeiss, Inc., Thornwood, NY).
For EM immunolocalization studies, cells were fixed with 2% glutaral-
dehyde (Polysciences, Inc.) in phosphate buffer (pH 7.4), infiltrated with
2.3 M sucrose, and processed for cryoultramicrotomy according to the
method of Tokuyasu (1986). Affinity-purified anti–ERS-24 antibodies (di-
luted 1:20) were localized with the protein A–gold method (Roth et al.,
1978) or by goat anti–rabbit IgG-coupled gold. Double immunolabeling of
ERS-24 and BiP was carried out by incubating thin cryosections with rab-
bit anti–ERS-24 (dilution 1:20) and mouse anti–BiP (dilution 1:50) anti-
bodies, followed by gold-tagged goat anti–rabbit IgG (size of gold parti-
cles 
 
5
 
 15 nm) and goat anti–mouse IgG (size of gold particles 
 
5
 
 10 nm).
After immunolabeling, sections were absorption stained with uranyl ace-
tate (Tokuyasu, 1986) and examined in the electron microscope.
 
Cell Fractionation by Equilibrium Sucrose Density 
Gradient Centrifugation
 
Wild-type CHO cells and a stable CHO cell line overexpressing ERS-24–
myc were used for the cell fractionation experiment. Postnuclear superna-
tants were prepared essentially as described (Dunphy and Rothman,
1983), layered on top of continuous sucrose density gradients (20–50% su-
crose [wt/wt]), and centrifuged in an SW 28 rotor (Beckman Instruments,
Inc., Palo Alto, CA) at 25,000 rpm (85,000 
 
g
 
) for 16 h. Gradient fractions
were collected, and membranes were pelleted at 100,000 
 
g
 
 for 1 h and re-
suspended in 2 
 
3
 
 Laemmli buffer (Laemmli, 1970). Proteins were sepa-
rated by 18% SDS-High-Tris-Urea-PAGE and processed for Western
blot analysis.
 
Results
 
Isolation and Cloning of ERS-24
 
SNAREs were isolated from Triton X-100–solubilized
whole cell membrane extracts prepared from RBL-2H3
cells, relying on their ability to assemble with SNAPs and
NSF into 20S particles in the presence of ATP
 
g
 
S (Wilson
et al., 1992; Söllner et al., 1993
 
a
 
). Subsequent addition of
MgATP resulted in the disassembly of the 20S complex
and release of individual SNAREs. One of the released
SNAREs migrated with an apparent molecular mass of
22 kD in 18% SDS-High-Tris-Urea-PAGE (Schlenstedt
et al., 1990). After electroblotting, this protein band was
excised from the nitrocellulose filter and processed for
internal amino acid sequence analysis essentially as de-
scribed (Tempst et al., 1990; Erdjument-Bromage et al.,
1994; Söllner et al., 1993
 
a
 
). Seven major tryptic fragments
were analyzed by microsequencing (Fig. 1).
To isolate a cDNA clone encoding this protein, degener-
ate PCR primers were designed based on the peptide se-
quence MQEDEQ in tryptic fragment T3 and FIEFET in
tryptic fragment T7 (Fig. 1 and Materials and Methods).
These degenerate primers were used for PCR amplifica-
tion from RBL-2H3 cDNA. One major PCR amplification
product of 300 bp in length was obtained and used as a
probe to screen a phage cDNA library from the CHO cell
Figure 1. Peptide sequences of a putative SNARE, with an ap-
parent molecular mass of 22 kD. Using detergent-solubilized to-
tal membrane fractions prepared from RBL-2H3 cells, putative
SNAREs were isolated from 20S particles after MgATP hydroly-
sis by NSF. Peptide sequences obtained from a SNARE, with an
apparent molecular mass of 22 kD (see Materials and Methods)
are shown. An “x” means that no residue could be identified at
this position. The peptide sequences used to design PCR primers
are underlined.
Figure 2. Nucleotide and amino acid sequence of ERS-24. The
nucleotide and amino acid sequence of a full-length cDNA clone
encoding ERS-24 is shown. The amino acid sequence is shown in
single-letter code above the nucleotide sequence; both are num-
bered on the right. The initiator methione is underlined; the as-
terisk after the amino acid sequence denotes a stop codon. The
carboxy-terminal transmembrane region is boxed. The peptide
sequences that were obtained from the SNARE isolated from the
20S particles (see Fig. 1) are underlined. 
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line (see Materials and Methods) to obtain full-length
cDNA clones.
Four clones were analyzed by DNA sequencing. All
four clones contain an identical open reading frame that
encodes a polypeptide of 215 amino acids (Fig. 2). The
predicted molecular mass of this protein is 24 kD and is in
close agreement with the apparent size of 22 kD in an 18%
SDS-High-Tris-Urea-PAGE. All seven tryptic peptide se-
quences previously identified by microsequencing were
encoded within the open reading frame, clearly demon-
strating that the cDNA clones encode the protein origi-
nally isolated from the 20S particles. A search of databases
revealed no identical matches; hence, this protein is a
novel mammalian protein. We now refer to this protein as
ERS-24.
 
ERS-24 Is Homologous to Sec22p and rsec22
 
Comparison of the deduced polypeptide sequence of
ERS-24 with the protein sequence data banks using the
BLAST search program revealed that ERS-24 shares sig-
nificant sequence homology to a known yeast v-SNARE,
Sec22p (Newman et al., 1990, 1992; Dascher et al., 1991)
(Fig. 3 
 
A
 
). These two proteins are overall 35% identical.
Furthermore, Kyte-Doolittle plots reveal that the car-
boxy-terminal two-thirds of these two proteins show al-
most identical hydrophobicity/hydrophilicity profiles (Fig.
3 
 
B
 
). Both proteins contain a carboxy-terminal hydropho-
bic segment that presumably acts as a membrane anchor.
ERS-24 has a short stretch of hydrophobic amino acids at
its amino-terminal end not found in Sec22p (Fig. 3, 
 
A
 
 and
 
B
 
). Both ERS-24 and Sec22p have heptad repeats of ali-
phatic residues in the carboxy-terminal region (residues
130–190) with a predicted propensity to form coiled-coils.
ERS-24 has an additional region (amino acids 16–48) that
has the potential to form coiled-coil structures. These re-
gions are presumably important for protein–protein inter-
actions (Lupas et al., 1991).
Recently, a rat homologue of Sec22p, rsec22 (Hay et al.,
1996), that shares 32% sequence identity with yeast Sec22p
(Fig. 3 
 
A
 
) was identified. Sequence alignment of ERS-24
(from hamster) and rsec22 (from rat) reveals that they are
35% identical, clearly demonstrating that ERS-24 and
rsec22 are different proteins. rsec22 has at its carboxy ter-
minus, beyond the putative transmembrane domain, a 46–
amino acid–long extension that is absent in both ERS-24
and Sec22p (Fig. 3 
 
A
 
). The striking similarity in the hydro-
phobicity/hydrophilicity profiles of ERS-24 and Sec22p is
not observed with rsec22 (Fig. 3 
 
B
 
).
ERS-24 is also homologous to a number of other puta-
tive v-SNAREs (18–28% sequence identity and 40–50%
similarity). Homologous v-SNAREs include the 
 
SAR1
 
gene product of 
 
Arabidopsis thaliana
 
 (Schena and Davis,
1992) (no relation to the yeast GTPase also termed SAR1
[Barlowe et al., 1993]); p26/Ykt6, a prenylated SNARE in
yeast (Søgaard et al., 1994); the yeast proteins Snc1p and
Snc2p (Protopopov et al., 1993); the mammalian cellubre-
vin (McMahon et al., 1993); and the neuronal synaptobre-
vins/VAMPs 1 and 2 from many different sources (Trim-
ble et al., 1988; Elferink et al., 1989; Baumert et al., 1989;
Archer et al., 1990; Südhof et al., 1989). Interestingly, most
of the homology resides within the carboxy-terminal one-
third of these proteins (amino acid residues 130–190), while
the amino-terminal halves of these proteins are widely di-
vergent. In contrast, the identities between ERS-24, Sec22p,
Figure 3. ERS-24 and Sec22p share significant sequence homology and similar hydropathy profile. (A) A colinear alignment of
polypeptide sequences of ERS-24, Sec22p, and rsec22. Identical amino acids are boxed in black; conservative changes are shaded in
gray. ERS-24 and Sec22p are 35% identical; ERS-24 (from hamster) and rsec22 (from rat) are 35% identical; Sec22p and rsec22 are
32% identical. Of note, the long carboxy-terminal extension beyond the predicted transmembrane domain of rsec22 (Hay et al., 1996) is
not present in ERS-24 and Sec22p. These sequence data are available from EMBL/DDBJ/GenBank under accession numbers P22214
(Sec22p), U42209 (rsec22), and U91742 (ERS-24). (B) Hydrophilicity/hydrophobicity profiles of ERS-24, Sec22p, and rsec22. 
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and rsec22 are evenly distributed over the entire proteins
(Fig. 3 
 
A
 
).
 
ERS-24 Is a Type II Integral Membrane Protein
 
According to the amino acid sequence (Fig. 2), ERS-24
should behave as an integral membrane protein with its
carboxy terminus anchored in the lipid bilayer. To test this,
a polyclonal antibody was generated using a bacterially
overexpressed recombinant ERS-24 protein. The affinity-
purified antibody recognized only one band with an appar-
ent molecular mass of 22 kD both in CHO and RBL-2H3
cells (Fig. 4 
 
A
 
), and one major band of 22 kD in dog pan-
creas microsomes (Fig. 4 
 
B
 
 and 
 
C
 
). When translocation-
competent dog pancreas microsomes were subjected to ei-
ther high salt (1 M NaCl) or high pH (100 mM Na
 
2
 
CO
 
3
 
,
pH 11.3) extraction (Fujiki et al., 1982), ERS-24 was found
exclusively in the pellet fraction of a high speed centrifu-
gation (100,000 
 
g
 
) (Fig. 4 
 
B
 
), indicating that it is an integral
membrane protein. In contrast, BiP, a protein resident in
the lumen of the ER (Haas and Wabl, 1983), was (as ex-
pected) found in the supernatant fraction under the same
experimental conditions.
Also, as expected for a SNARE (see Kutay et al., 1993),
the NH
 
2
 
 terminus of ERS-24 is exposed to the cytoplasm.
ERS-24 was sensitive to proteinase K (1 
 
m
 
g/ml) and was
degraded either in the absence or presence of Triton X-100
(Fig. 4 
 
C
 
). As a control for the integrity of the microsomes
used, BiP was found to be entirely protected from protein-
ase K digestion in the absence but not the presence of Tri-
ton X-100. These results demonstrate that the bulk of
ERS-24 is cytoplasmically oriented, and that ERS-24 is
membrane anchored by its hydrophobic COOH terminus
as a type II membrane protein, a feature commonly noted
in many SNAREs (Kutay et al., 1993).
 
ERS-24 Is Localized to the ER and the Golgi
 
The sequence homology between ERS-24 and yeast Sec22p
suggests that ERS-24, like Sec22p, plays a role in vesicle
traffic between the ER and the Golgi, and thus should be
associated, at least temporarily, with both compartments.
Sec22p (along with Bos1p) has been found in the transport
vesicles derived from the ER (Lian and Ferro-Novick,
1993; Barlowe et al., 1994), and the transport vesicles con-
taining Bos1p and Sec22p have been shown to be required
 
Figure 4. ERS-24 is a type II integral membrane protein with the
bulk of its mass exposed to the cytoplasm. (A) Affinity-purified
anti–ERS-24 antibodies recognize one distinct band in CHO and
RBL-2H3 cells. Triton X-100–solubilized total membrane ex-
tracts (100 mg protein) from CHO and RBL-2H3 cells were frac-
tionated on 18% SDS-High-Tris-Urea-PAGE, transferred onto
nitrocellulose, and immunodecorated with affinity-purified anti–
ERS-24 antibody. (B) ERS-24 is an integral membrane protein.
Translocation-competent dog pancreas microsomes were incu-
bated for 30 min on ice in the presence of the following buffers:
250 mM sucrose, 50 mM KOAc, 10 mM Hepes/KOH, pH 7.2
(lanes 1 and 2); 10 mM Tris-HCl, pH 7.2 (lanes 3 and 4); 1 M
NaCl, 10 mM Tris-HCl, pH 7.2 (lanes 5 and 6); and 100 mM
Na2CO3, pH 11.3 (lanes 7 and 8). Membranes were isolated by
centrifugation at 100,000 g and supernatants were precipitated
with TCA. Membranes (P) and supernatants (S) were analyzed
by 18% SDS-High-Tris-Urea-PAGE, transferred onto nitrocellu-
lose, and immunodecorated with either monoclonal anti-BiP (grp
78) antibodies (StressGen) (top) or affinity-purified polyclonal
anti–ERS-24 antibodies ( bottom). (C) The bulk of ERS-24 is ex-
posed to the cytoplasm. Translocation-competent, salt-washed dog
pancreas microsomes (25 mg) were incubated with the indicated
amounts (mg/ml) of proteinase K either in the presence (lanes 1–5)
or absence (lanes 6–10) of Triton X-100. The proteinase K digest
was carried out at room temperature for 10 min and terminated
by addition of PMSF (1 mM). The reaction mixtures were TCA
precipitated, fractionated on 18% SDS-High-Tris-Urea-PAGE,
transferred onto nitrocellulose, and immunodecorated either
with monoclonal anti-BiP (grp 78) antibody (StressGen) (top) or
affinity-purified polyclonal anti–ERS-24 antibody (bottom).The Journal of Cell Biology, Volume 137, 1997 1022Paek et al. ERS-24, a Mammalian v-SNARE 1023
for fusion with a Golgi compartment (Lian and Ferro-
Novick, 1993; Lian et al., 1994). Sec22p therefore has been
previously assigned to the ER in yeast. Immunolocaliza-
tion studies are difficult in yeast because of the absence of
a morphologically well-defined Golgi. The isolation of
ERS-24 in mammalian cells now provides an opportunity
to perform more detailed localization studies. For these
studies, it was necessary to overexpress ERS-24 since our
polyclonal anti–ERS-24 antibody was not sensitive enough
to detect ERS-24 in normal cells. We therefore used a sta-
Figure 5. Immunofluorescence localization of ERS-24 in CHO cells. Indirect immunofluorescence localization of ERS-24–myc and BiP
in the stably transfected CHO cell line. Cells were double labeled with affinity-purified polyclonal anti–ERS-24 antibody and mono-
clonal anti-BiP (grp 78) antibody (StressGen). (A) ERS-24–myc–containing intracellular structures were visualized by incubating with
FITC-conjugated, goat anti–rabbit IgG. (B) BiP-containing ER was visualized using Texas red–conjugated goat anti–mouse IgG. The
distinct juxtanuclear regions, characteristic of the Golgi (arrowheads), are exclusively labeled by anti–ERS-24 antibody. 
Figure 6. Immuno-EM localiza-
tion of ERS-24 to the ER and
the Golgi region. (A) Immuno-
EM visualization of the ER–
Golgi area in a CHO cell line
stably transfected with ERS-24–
myc. Ultrathin cryosections of
the glutaraldehyde-fixed cells
were double labeled for BiP (10
nm gold) and ERS-24 (15 nm
gold). The ER compartment to
the middle left shows labeling
for both BiP and ERS-24. By
comparison, in the Golgi com-
plex (G) to the upper right, only
the ERS-24 label is present. B
and  C are single labeled for
ERS-24. (B) Gold particles are
present at various levels of a
Golgi stack (G). (C) ERS-24 la-
beling is seen on both the fenes-
trated plate on the cis-Golgi
pole and on vesicles associated
with the terminal rim of the cis-
ternae (right, arrowhead). Tubu-
lar profiles of the cis-Golgi plate
in cross-section are indicated by
arrows. Bars, 200 nm.The Journal of Cell Biology, Volume 137, 1997 1024
ble CHO cell line that overexpresses an ERS-24 fusion
protein, ERS-24–myc, containing a carboxy-terminal myc
epitope (EQKLISEEDL; Evan et al., 1985). Immunofluo-
rescence microscopy using the affinity-purified polyclonal
antibody against ERS-24 showed a reticular staining pat-
tern characteristic of the ER (Fig. 5 A). In addition, how-
ever, a clear juxtanuclear labeling pattern reminiscent of
the Golgi (Fig. 5 A, arrowheads) was noted, suggesting
that ERS-24–myc may reside in both of these compart-
ments. Similar results were obtained with the monoclonal
anti-myc (9E10) antibody (Evan et al., 1985; data not
shown). In double labeling, a control monoclonal anti-BiP
(grp 78) antibody (StressGen) directed against the peptide
KSEKDEL found at the carboxy terminus of BiP and
other luminal ER proteins (Munro and Pelham, 1987)
highlighted the reticular network of the ER, but not the
juxtanuclear region containing the Golgi (Fig. 5 B).
The subcellular localization of ERS-24–myc to the ER
and the Golgi was firmly established by the immunoEM
analysis. Fig. 6 A shows the colocalization of ERS-24–myc
and BiP to the ER (left side). In comparison, only ERS-
24–myc is seen in the Golgi complex (Fig. 6 A, upper
right). While ERS-24–myc is qualitatively present in multi-
ple Golgi cisternae (Fig. 6 B) it seems to be concentrated
at the fenestrated pole of the cis-most Golgi cisternae (Fig.
6 C, arrows). In addition, ERS-24–myc is found in vesicles
associated with the terminal rim of the Golgi cisternae
(Fig. 6 C, arrowhead). Quantitative analysis of the im-
muno-EM localization studies showed (see Table I) that
the ERS-24–myc signal was enriched in these vesicles posi-
tioned lateral to the Golgi stack and in transfer vesicles
found in the transition area of the ER. This labeling pat-
tern is highly suggestive of an efficient incorporation of
ERS-24–myc into transport vesicles, and is consistent with
its predicted function as a v-SNARE involved in vesicle
transport between the ER and the Golgi.
The localization of ERS-24 to the ER and the Golgi was
independently confirmed by subcellular fractionation stud-
ies. In these studies, wild-type CHO cells and the stable
CHO cell line overexpressing ERS-24–myc (the same cells
used for immuno-EM) were used to control for potential
changes in localization of ERS-24, resulting from overex-
pression or epitope tagging. Postnuclear fractions were
fractionated by equilibrium density centrifugation using
continuous sucrose gradients. Fig. 7, A and B, shows that
resident proteins of the ER, such as BiP (Munro and Pel-
ham, 1986) and SSR-a (Wada et al., 1991), and markers of
the Golgi, such as syntaxin 5 (Banfield et al., 1994) and
GOS-28 (Nagahama et al., 1996; Subramaniam et al., 1996),
can be clearly separated on sucrose density gradients after
equilibrium centrifugation. The endogenous ERS-24 in
wild-type CHO cells has a broad distribution in this su-
crose gradient, but nevertheless can be grouped into two
populations (Fig. 7 A). One population of ERS-24 in the
heavier sucrose density fractions shows overlapping, but
not identical, distribution with proteins that had been pre-
viously localized to the ER, such as SSR-a (Wada et al.,
1991) and BiP (Munro and Pelham, 1986). The second and
most abundant population of ERS-24 is in the lighter su-
crose density fractions and shows an overlapping distribu-
Table I. Enrichment of ERS-24 in Transport Vesicles
Cell compartment* Density of ERS-24–myc
number of gold particles per mm2
Rough ER‡ 36 6 10
Transfer vesicles in the
transition area of ER 63 6 11
Vesicles positioned
lateral to the Golgi stack 55 6 10
Golgi stack 20 6 4
Nucleus§ 5 6 1
A CHO cell line stably transfected with ERS-24–myc was used for immuno-EM lo-
calization studies. Cells were fixed with 2% glutaraldehyde, infiltrated with 2.3 M su-
crose, and processed for cryoultramicrotomy. Ultrathin cryosections were incubated
with affinity-purified anti–ERS-24 antibody (diluted 1:20), followed by incubation
with goat anti–rabbit IgG–gold (gold size 15 nm). Shown is the mean value of the
number of gold particles per mm2 followed by the SEM.
*Only the cells showing ERS-24 immunolabeling on the Golgi complex were in-
cluded in this study. It was not infrequent to see cells with no labeling of the Golgi
complex.
‡Including the nuclear envelope.
§Except the nuclear envelope.
Figure 7. Cofractionation of ERS-24 with markers of the ER and
the Golgi. A Western blot analysis of the sucrose density gradient
fractions of cell lysates prepared from the wild-type CHO cells
(A) and a stable CHO cell line overexpressing ERS-24–myc fu-
sion protein (B). Nitrocellulose filters were immunodecorated
with polyclonal antibody against the amino-terminal portion of
BiP, polyclonal anti-p58 antibody, polyclonal anti-SSRa anti-
body, affinity-purified polyclonal anti–syntaxin 5 antibody, affin-
ity-purified polyclonal anti–GOS-28 antibody, and affinity-puri-
fied polyclonal anti–ERS-24 antibody.Paek et al. ERS-24, a Mammalian v-SNARE 1025
tion with several proteins previously localized to the Golgi
region, including syntaxin 5 (Bennett et al., 1993; Banfield
et al., 1994) and GOS-28 (Nagahama et al., 1996; same as
GS-28, Subramaniam et al., 1996).
The fusion protein, ERS-24–myc, and the endogenous
ERS-24 share a similar bimodal subcellular distribution in
the CHO cell line overexpressing the ERS-24–myc fusion
protein (Fig. 7 B). Therefore, it is unlikely, although it can-
not be excluded, that epitope tagging at the carboxy termi-
nus per se alters the localization of ERS-24. However, it
appears that the overexpression of total ERS-24 (endoge-
nous plus recombinant ERS-24–myc) increases the rela-
tive amount of both the endogenous ERS-24 and the ERS-
24–myc fusion protein in the dense ER-containing sucrose
fractions (Fig. 7 B). The reason for this is not clear. Never-
theless, endogenous ERS-24 (expressed at native levels) is
largely Golgi localized, suggesting that the majority of na-
tive ERS-24 may be present in the Golgi at any one moment.
In sum, the morphological data and subcellular fraction-
ation studies confirm that ERS-24 is localized to both the ER
and the Golgi, suggesting a role for ERS-24 in the vesicle
traffic between and possibly within these two compartments.
ERS-24 Interacts with Syntaxin 5 in 20S
Particles and the ATPase Activity of NSF Destabilizes 
This Interaction
SNAREs are characterized by their ability to associate with
SNAPs, particularly when they are assembled in v–t-SNARE
complexes (Söllner et al., 1993b; Hayashi et al., 1995). The
resulting complex subsequently binds NSF, whose ATPase
activity then releases SNAPs and the individual SNAREs
(Söllner et al., 1993b). Indeed, ERS-24 from Triton X-100
extracts of CHO cells likely assembled in a v–t-SNARE
complex binds to a-SNAP (Fig. 8 A, lanes 3) and remains
bound when NSF is added in the presence of ATPgS/
EDTA (Fig. 8 A, lane 4). In the presence of MgATP, NSF
hydrolyzes ATP and ERS-24 is released from the immobi-
lized a-SNAP (Fig. 8 A, lane 6). This confirms that ERS-
24 is an a-SNAP receptor and, when bound to SNAP (and
possibly other proteins), is a substrate for NSF-dependent
complex disruption.
In Fig. 8 B (lane 1), we show that ERS-24 interacts with
syntaxin 5, the mammalian counterpart of Sed5p (Bennett
et al., 1993; Banfield, 1994) in 20S docking and fusion par-
ticles that can be immunoprecipitated with antibody to
ERS-24. Syntaxin 5 is released when NSF hydrolyzes ATP
(Fig. 8 B, lane 2). This is in agreement with the previous
observation that Sed5p forms a multimeric v- and t-SNARE
complex in yeast containing Sec22p under nonpermissive
temperature in NSF mutant sec18 strains (Søgaard, et al.,
1994). The nature of the larger band (Fig. 8 B, asterisk), mi-
grating at 42 kD is currently unknown, but it may represent a
syntaxin homologue or a modified form of syntaxin 5. This
protein also assembles into 20S particles with ERS-24 and
undergoes ATP-dependent dissociation.
Figure 8. ERS-24 interacts
with syntaxin 5 in 20S parti-
cles, and the ATPase activity
of NSF disrupts this interac-
tion. (A) The binding of
ERS-24 from Triton X-100
extract of CHO cells to the
recombinant GST–a-SNAP
fusion protein and subse-
quent disassembly of ERS-24
from 20S particles in the
presence of NSF and
MgATP. Triton X-100–solu-
bilized total CHO mem-
branes (200 mg protein) and
GST–a-SNAP fusion pro-
tein (1 mg) immobilized onto
glutathione beads were incu-
bated, either in the presence of ATPgS (lanes 1–4) or MgATP (lanes 5 and 6), in 1 ml buffer containing 20 mM Hepes-KOH, pH 7.0,
100 mM KCl, 1% glycerol, 1 mM DTT, 0.5% Triton X-100. To samples 2, 4, and 6, recombinant (His)6-NSF-myc (5 mg protein) was
added. (Lanes 1 and 2) Controls for nonspecific binding to GST–glutathione beads in buffer containing ATPgS, either in the absence
(lane 1) or presence (lane 2) of recombinant (His)6-NSF-myc. The samples were washed four times with 1 ml of the incubation buffer
containing either ATPgS or MgATP, and then analyzed by Western blotting and immunodecoration with affinity-purified anti–ERS-24
antibody. Of note, the polyclonal anti–ERS-24 antibody, which was raised against ERS-24–myc (His)6, recognizes also the (His)6 tag or/
and myc tag of recombinant (His)6-NSF-myc. (B) The assembly of ERS-24 with syntaxin 5 in 20S particles in the presence of ATP/
EDTA and disruption of this interaction in the presence of the ATPase activity of NSF. Triton X-100–solubilized total CHO mem-
branes (500 mg protein) were incubated with recombinant (His)6-a-SNAP and (His)6-NSF-myc (5 mg of each protein), either in the
presence of ATP/EDTA (lane 1) or MgATP (lane 2), in the above-mentioned incubation buffer for 1 h at 48C. Affinity-purified anti–
ERS-24 antibody, covalently coupled to protein A–agarose (as described in Söllner et al., 1993), was added and the incubation was con-
tinued overnight at 48C. The samples were washed four times with 1 ml of incubation buffer containing either ATP/EDTA (lane 1) or
MgATP (lane 2), and the immunoprecipitate was analyzed by Western blotting. The blot was cut into two sections. The upper section,
containing the higher Mr proteins, was probed with affinity-purified anti–syntaxin 5 antibody, and the lower section containing the
lower Mr proteins was probed with affinity-purified anti–ERS-24 antibody. The anti–syntaxin 5 antibody recognized two protein bands.
The band at 35 kD (syntaxin 5) comigrates with its bovine counterpart whose identity has been confirmed by peptide sequencing (data
not shown). The nature of the 42 kD band (asterisk) is currently unknown.The Journal of Cell Biology, Volume 137, 1997 1026
Discussion
In this paper we report the isolation and characterization
of a new mammalian v-SNARE, ERS-24, that meets all of
the known criteria for a SNARE including its ability to
bind to a-SNAP and to assemble into a 20S particle. Its in-
teraction with a-SNAP might be direct, or indirect with
ERS-24 being assembled in a v–t-SNARE complex with
other SNAREs. The ATPase activity of NSF disassembles
the 20S particle and releases ERS-24. ERS-24 is primarily
localized to the ER and the Golgi but may be mainly in the
Golgi at any one moment when expressed at native levels.
Overexpression for unknown reasons changes the distri-
bution in favor of the ER.
ERS-24 is homologous to a large number of v-SNAREs
but is most homologous to both yeast Sec22p (Newman
et al., 1990; Dascher et al., 1991) and rsec22, another mam-
malian homologue of Sec22p (Hay et al., 1996) that is pre-
dominantly localized to the ER. These three proteins
share sequence identities of z32–35%.
Sec22p is a v-SNARE required for the vesicle traffic be-
tween the ER and the Golgi (Lian and Ferro-Novick,
1993; Barlowe et al., 1994). The function of rsec22 has not
been determined. Given this level of identity, it is not pos-
sible to say whether or not both ERS-24 and rsec22 are
functionally equivalent (in mammalian cells) to Sec22p (in
yeast), or whether they serve a different (but similar) role
to the true homologue of Sec22p in mammals.
While there is no formal proof that ERS-24 is a v-SNARE
needed for the vesicle traffic between the ER and the
Golgi, the significant homology to Sec22p, its interaction
with syntaxin 5, and its localization to these organelles sug-
gests this possibility. Such proof awaits the demonstration
that ERS-24 is packaged into the COPI- and/or COPII-
coated vesicles that depart the ER, as has been shown for
Sec22p (Barlowe et al., 1994; Bednarek et al., 1995), and is
needed for attachment to Golgi membranes, as has been
shown with the transport vesicles containing Bos1p and
Sec22p in yeast (Lian and Ferro-Novick, 1993). Neverthe-
less, we have shown that ERS-24 is enriched in vesicles in
the transition area of the ER and in vesicles associated
with the terminal rim of the Golgi cisternae in vivo, and it
is incorporated into Golgi-derived COPI-coated transport
vesicles formed in vitro (data not shown), suggesting that
ERS-24 cycles between the ER and the Golgi, as expected
for a v-SNARE shuttling cargo molecules between these
two compartments.
EM shows that ERS-24 is not strictly restricted to the
cis-pole of the Golgi, as one might simply expect for a
v-SNARE exclusively involved uni- or bidirectionally in
transport between ER and Golgi. Whether ERS-24 plays a
functional role in intercisternal transport is unknown, even
if it is localized in post–cis-Golgi vesicles to some extent.
The presence of ERS-24 in later Golgi cisternae could eas-
ily be explained by a retrieval system that is ,100% effi-
cient, as for escaped ER resident proteins. Depending on
the probability with which ERS-24 enters retrograde trans-
port vesicles, a more or less steep concentration gradient
of ERS-24 across the Golgi stack would be established in
distillation (Rothman, 1981; Rothman and Wieland, 1996).
Since ERS-24 is enriched in vesicles and buds at the rims
of the Golgi, an exact assignment to individual cisternae is
very difficult, thereby precluding the kind of quantitation
that would be necessary to establish the definitive extent
of an ERS-24 concentration gradient across the Golgi stack.
Regarding the question of whether ERS-24 could play
an active role in targeting transport vesicles derived from
the Golgi to their destination, or is rather just a passenger,
i.e., a component of transport machinery that needs to be
recycled, it is noteworthy, although not conclusive, that
neither anti–ERS-24 antibodies nor the cytoplasmic do-
main of ERS-24 inhibited the cell-free Golgi transport re-
action or the assembly of ERS-24 into 20S particles (data
not shown). This in no way reduces the likelihood of the
possibility that ERS-24 could serve as a v-SNARE target-
ing vesicles that budded from any level of the Golgi stack
to the ER, among other possibilities. To address such is-
sues, it will be necessary to identify additional components
that are temporally associated with and/or regulate the ac-
tivities of ERS-24. For example, in yeast Sed5p interacts
with Sec22p and several other (predicted) v-SNAREs in-
cluding Bos1p, Bet1p, and p26/Ykt6p, and is implicated in
the vesicle traffic between the ER and the Golgi (Søgaard
et al., 1994). ERS-24, a potential mammalian homologue
of Sec22p, similarly interacts with syntaxin 5, a likely coun-
terpart of Sed5p, in 20S docking and fusion particles.
Whether syntaxin 5 is the sole partner t-SNARE interact-
ing with ERS-24 remains to be determined. The identifica-
tion of other potential interacting partners of ERS-24 shall
provide insight into the function of ERS-24 in the vesicle
flow between the ER and the Golgi and possibly within
successive layers of the Golgi, increasing our understand-
ing about how the activity of ERS-24 is regulated.
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